We examined whether acetylcholine release in the hippocampus and striatum and noradrenaline release in the hippocampus is altered in CB 1 receptor-de®cient mice. 
Introduction Presynaptic cannabinoid CB 1 receptors have been shown to occur on various neurones of the peripheral and central nervous system; activation of these receptors causes inhibition of the release of the respective neurotransmitter (for review, see Pertwee, 1997; Ameri, 1999) . For the identi®cation of CB 1 receptors the advent of selective CB 1 receptor antagonists, in particular SR 141716, was very important (for review, see . When given alone, SR 141716 facilitates neurotransmitter release in a series of experimental models, e.g., acetylcholine release in the hippocampus, as shown by Giord & Ashby (1996) (rat in vitro) and Kathmann et al. (2000) (mouse in vitro) . This ®nding may mean that the CB 1 receptors are activated by endogenously formed cannabinoids (`endocannabinoids'; for review, see Mechoulam et al., 1998) . Since SR 141716 proved to be an inverse agonist under certain circumstances (for review, see Shire et al., 1999) , another explanation might be that the CB 1 receptors in these experimental models are constitutively active. Both mechanisms would be in harmony with the notion that the CB 1 receptors under consideration may play a physiological role.
CB 1 receptor-de®cient mice have been described recently Zimmer et al., 1999) and oer an additional method to check the potential physiological role of the CB 1 receptor. This genetic approach oers several advantages over the pharmacological blockade of the CB 1 receptor, most importantly an increased receptor speci®city and completeness of receptor inactivation. Another advantage over the use of SR 141716 is that the lack of receptor and/or its associated function is not restricted to the moment of the experiment but is persistent. Using the CB 1 receptor knock-out mouse generated by Zimmer et al. (1999) , we examined whether CB 1 receptor disruption alters acetylcholine release from the hippocampus. For the sake of comparison, acetylcholine release from the striatum and noradrenaline release from the hippocampus, both of which are not subject to modulation via CB 1 receptors (Schlicker et al., 1997; Kathmann et al., 2001) , were considered as well.
Methods C57BL/6J mice with disrupted CB 1 receptor gene (CB 1 7/7 mice; obtained from A. Zimmer) and C57BL/6J mice of the wild type strain (CB 1 +/+ mice; purchased from Jackson, Bar Harbor, ME, U.S.A.) were bred in the animal facilities of our department. All animals were housed in a temperature-and humidity-controlled vivarium with a 12-h dark ± light cycle. Food and water were available ad libitum. For the experiments, hippocampal or striatal slices (0.3 mm thick, 2 mm diameter) were prepared from 8 ± 16 week old animals. In each experiment, slices from a CB 1 +/+ and a ions (from 62 min of superfusion onward) inhibited the electrically evoked tritium over¯ow by 89% or more (results not shown).
Tritium eux was calculated as the fraction of the tritium content in the slices at the beginning of the respective collection period (fractional rate of tritium eux). To quantify basal eux, the fractional rates in the 5-min collection period from 85 ± 90 min were determined. The electrically evoked tritium over¯ow was calculated by subtraction of basal from total eux during stimulation and the subsequent 13 min and expressed as per cent of the tritium present in the slice at the onset of stimulation (basal tritium eux was assumed to decline linearly from the 5-min collection period before to that 15 ± 20 min after onset of stimulation). To quantify the stimulated tritium over¯ow, the tritium over¯ow evoked by S 1 or the ratio of the over¯ow evoked by S 2 over that evoked by S 1 was determined, as explained in the Results section.
Statistics Results are given as means+s.e.mean of n experiments (n refers to the number of animals). Student's t-test was used for comparison of mean values; the Bonferroni correction was used when two or more values were compared to the same control. Figure 1B) . On the other hand, the evoked tritium over¯ow in hippocampal slices from CB 1 7/7 mice preincubated with [ 3 H]-choline strongly exceeded that in hippocampal slices from wild type mice. This held true for the standard experimental condition (increase by 102%) but also when the Ca 2+ concentration in the superfusion medium was lowered from 3.25 to 2.6 or 1.95 mM, when slices from female animals were used or when the muscarinic autoreceptors were blocked by AF-DX 384 ( Figure 1A ). The increase in the electrically evoked tritium over¯ow at the Ca 2+ concentration of 1.95 mM was signi®cantly (P50.025) higher than that under the standard experimental condition.
Effect of cannabinoid receptor ligands on the electrically evoked tritium overflow To study the eect of drugs on the evoked tritium over¯ow, the ratio of the over¯ow evoked by S 2 over that evoked by S 1 was determined. The cannabinoid receptor agonist WIN 55,212-2 or the CB 1 receptor antagonist SR 141716 was added to the medium before and during S 2 . (Richardson & Szerb, 1974) . Since, in addition, the electrically evoked tritium over¯ow was Ca 2+ -dependent and tetrodotoxin-sensitive in our experiments we can assume that it represents quasiphysiological acetylcholine and noradrenaline release, respectively, and we used these terms in the following text.
If one applies the same stimulation protocol in order to evoke acetylcholine and noradrenaline release (S 1 , expressed as per cent of tissue tritium), the amount of noradrenaline will exceed that of acetylcholine by a factor of more than 10 (unpublished results). For this reason, we used a higher stimulation frequency and a higher current strength to evoke acetylcholine release. Since, nonetheless, the amount of released acetylcholine was very low in hippocampal slices from CB 1 +/+ (C57BL/6J) mice (Kathmann et al., 2001) , the Ca 2+ concentration in the superfusion medium was stepwise increased to 1.95, 2.6 and 3.25 mM. Most of the experiments in which acetylcholine release was studied were carried out at 3.25 mM since at this Ca 2+ concentration S 1 values higher than 1.5% of tissue tritium were obtained. Note that, at lower S 1 values, the S 2 /S 1 ratios (used to quantify the eects of drugs on transmitter release, e.g. in Table 1 ) will show a very high variation.
The major ®nding of the present investigation is that acetylcholine release was about twice as high in the hippocampus from CB 1 receptor-de®cient mice when compared to wild type animals. This increase was found under three dierent Ca 2+ concentrations in the superfusion medium and in slices from male and female mice. One might think that the increase in transmitter release in the knock-out animals is a more general phenomenon. This, however, does not appear to hold true since the release of the same transmitter in another brain region (striatum) and the release of another transmitter (noradrenaline) in the same brain region did not show a dierence between CB 1 +/+ and CB 1 7/7 mice. Moreover, one might assume that the increase in acetylcholine release is related to a compromised function of the muscarinic autoreceptor. This possibility can be excluded since the increase in acetylcholine release also occurred when the muscarinic autoreceptor was blocked in slices from CB 1 receptor-de®cient and wild type mice. In addition, the Figure 1 Electrically evoked tritium over¯ow from superfused hippocampal and striatal slices from CB 1 +/+ (empty columns) and CB 1 7/7 mice (®lled columns). Tritium over¯ow was evoked after 40 min of superfusion (S 1 ; and again after 90 min, not shown). Hippocampal slices from male CB 1 +/+ and CB 1 7/7 mice were preincubated with [ 3 H]-choline and then superfused with medium (Ca 2+ 3.25 mM) containing hemicholinium-3 10 mM; stimulation parameters were 3 Hz, 200 mA, 2 ms. The results of this series (standard condition) are depicted in A. In additional series (A and B), (i) the Ca 2+ concentration was lowered, (ii) slices from female mice were used, (iii) a muscarinic receptor antagonist (AF-DX 384) was present in the medium, (iv) striatal slices were used or (v) hippocampal slices preincubated with [ 3 H]-noradrenaline were used. In the latter series, superfusion was carried out with medium (Ca 2+ 1.3 mM) containing desipramine 1 mM and rauwolscine 1 mM and the stimulation parameters were 0.3 Hz, 50 mA, 2 ms. Data are expressed as means+s.e.mean of 5 ± 14 experiments. *P40.05, **P50.005. Tritium over¯ow was evoked at 3 Hz (slices preincubated with [ muscarinic receptor agonist oxotremorine caused a very marked inhibition of acetylcholine release in hippocampal slices from CB 1 7/7 mice (maximum inhibition by 80%; unpublished results), which was comparable to that found in the hippocampus from NMRI mice (Kathmann et al., 2001) .
A plausible explanation for the selective increase in hippocampal acetylcholine release in CB 1 7/7 mice would be that the release of this transmitter is dis-inhibited due to the disruption of tonically activated or constitutively active presynaptic CB 1 receptors on cholinergic neurones (see Introduction). The following ®ndings are in line with this notion. (i) The CB 1 receptor antagonist SR 141716 facilitated acetylcholine release in hippocampal slices from CB 1 +/+ mice (Kathmann et al., 2001; present study mice. An auxiliary experimental series on hippocampal slices from CB 1 +/+ mice (not shown) revealed that WIN 55,212-2 inhibited acetylcholine release in a concentration-dependent manner and that its concentration-response curve was shifted to the right by SR 141716, yielding an apparent pA 2 value of 8.1, which is similar to that obtained in other CB 1 receptor models (e.g., Schlicker et al., 1997; Kathmann et al., 2001) .
The possibility cannot be excluded that other mechanisms may account for the selective increase in hippocampal acetylcholine release in CB 1 7/7 mice, which, e.g., might represent a compensatory change in response to the alteration of the release of other transmitters. Irrespective of the mechanism, our ®nding is interesting inasmuch as several lines of evidence suggest that the eects of cannabinoids on learning and memory may be causally related to an alteration of the septohippocampal cholinergic system. Thus, learning and memory processes are negatively in¯uenced by cannabinoid receptor agonists (for reviews, see Hampson & Deadwyler, 1999; Sullivan, 2000) but facilitated by SR 141716 (Terranova et al., 1996; Lichtman, 2000) or CB 1 receptor disruption (Reibaud et al., 1999) and hippocampal acetylcholine release is inhibited by cannabinoid receptor agonists but facilitated by SR 141716 (Giord & Ashby, 1996; Gessa et al., 1997; Kathmann et al., 2001 ; present study) or CB 1 receptor disruption (present study). Moreover, the impairment of working memory in the rat by a cannabinoid receptor agonist is reversed by the cholinesterase inhibitor eptastigmine (Braida & Sala, 2000) and the facilitatory eect of SR 141716 on memory processes in the rat is partially antagonized by the muscarinic receptor antagonist scopolamine (Terranova et al., 1996) . It has to be stressed, however, that the evidence is not unequivocal. Thus, in the study by Acquas et al. (2000) cannabinoid receptor agonists did not inhibit but rather increased hippocampal acetylcholine release in the rat in vivo. Furthermore, the D 9 -tetrahydrocannabinolinduced impairment of a memory task in the rat was not counteracted by the cholinesterase inhibitor physostigmine and the impairment of the same task by scopolamine was not counteracted by SR 141716 (Lichtman & Martin, 1996) . Even if the role of our ®nding with respect to learning and memory is not yet clear, this ®nding represents a new piece of evidence in favour of tonically activated or constitutively active CB 1 receptors.
